1) Adkins PRF, Fox LK, Godden S, Jayarao BM, Keefe G, Kelton D, Lago A, Middleton JR, Owens W, Petersson-Wolfe C, Pighetti G, Quesnell R, Royster E, Ruegg P, Smith KL, Timmerman J. Laboratory Handbook on Bovine Mastitis, 3rd ed., New Prague, MN, USA: National Mastitis Council Inc., 2017.
2) Apparao MD, Ruegg PL, Lago A, Godden S, Bey R, Leslie K. Relationship between in vitro susceptibility test results and treatment outcomes for gram-positive mastitis pathogens following treatment with cephapirin sodium. J Dairy Sci 92, 2589-2597, 2009.
3) Balouiri M , Sadiki M, Ibnsouda SK. Methods for in vitro evaluating antimicrobial activity: A review. J Pharm Anal 6, 71–79, 2016
4) Barlow J. Mastitis therapy and antimicrobial susceptibility: A multispecies review with a focus on antibiotic treatment of mastitis in dairy cattle. J Mammary Gland Biol Neoplasia 16, 383-407, 2011.
5) Blowey R, Edmondson P. Mastitis Control in Dairy Herds, 2nd ed., Cambridge, MA: CABI Publishing, 2010.
6) Briyne ND, Atkinson J, Pokludová L, Borriello SP, Price S. Factors influencing antibiotic prescribing habits and use of sensitivity testing amongst veterinarians in Europe. Vet Rec 173, 475, 2013.
7) CLSI. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals, VET01. 5th ed., Wayne, PA, USA: CLSI, 2018.
8) CLSI. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals, VET08. 4th ed., Wayne, PA, USA: CLSI, 2018.
9) Fang W, Pyörälä S. Mastitis-causing escherichia coli: Serum sensitivity and susceptibility to selected antibacterials in milk. J Dairy Sci 79, 76-82 ,1996.
10) Harada K, Asai T. Role of antimicrobial selective pressure and secondary factors on antimicrobial resistance prevalence in escherichia coli from food-producing animals in japan. J Biomed Biotechnol 2010, 180682, 2010.
11) Hoe FGH, Ruegg PL. Relationship between antimicrobial susceptibility of clinical mastitis pathogens and treatment outcome in cows. J Am Vet Med Assoc 227, 1461-1468, 2005.
12) Hogan JS, Berry EA, Hillerton JE, Hogeveen H, Nickerson SC, Oliver SP, Pighetti GM, Rapnicki P, Schukken YH, Smith KL. Current Concepts of Bovine Mastitis, 5th ed., New Prague, MN, USA: National Mastitis Council Inc., 2017.
13) Hogeveen H, Huijps K, Lam TJGM. Economic aspects of mastitis: New developments. N Z Vet J 59, 16-23, 2011.
14) Kiku Y. Recent occurrences and control strategy of bovine mastitis based on questionnaraire survey in Japan. Kachiku Kansensho Gakkai Shi (The Journal of Farm Animal in Infectious Disease) 4, 109-132, 2015. (Japanese). http:// www.kachikukansen.org/kaiho2/PDF/4-3-109.pdf
15) Lee CR, Cho IH, Jeong BC, Lee SH. Strategies to minimize antibiotic resistance. Int J Environ Res Public Health, 10, 4274-4305, 2013.
16) Ministry of Agriculture, Forestry and Fisheries Economic Affairs Bureau. Clinical pathological examination procedure in the livestock insurance system. Kachiku Kyosai Ni Okeru Rinsho Byori Kensa Yoryo, Ministry of Agriculture, Forestry and Fisheries Economic Affairs Bureau, Tokyo, Japan. pp.77-78, 1997. (Japanese).
17) Morley PS, Apley MD, Besser TE, Burney DP, Fedorka-Cray PJ, Papich MG, et al. Antimicrobial drug use in veterinary medicine. J Vet Intern Med 19, 617-629, 2005.
18) Myllys V, Louhi M, Ali-Vehmas T. Comparison of Penicillin-G susceptibility testing methods of staphylococci isolated from bovine mastitits. Zentralbl Veterinarmed B, 39, 723-731, 1992.
19) Oliver SP, Murinda SE, Jayarao BM. Impact of antibiotic use in adult dairy cows on antimicrobial resistance of veterinary and human pathogens: A comprehensive review. Foodborne Pathog Dis 8, 337-355, 2011.
20) Owens WE, Watts JL. Effects of milk on activity of antimicrobics against staphylococcus aureus isolated from bovine udders. J Dairy Sci 70, 1946-1951, 1987.
21) O w en s WE, Watts JL. An timic r obial susceptibility and β-lactamase testing of staphylococci isolated from dairy herds. J Dairy Sci 71, 1934-1939, 1988.
22) Pol M, Ruegg PL. Relationship between antimicrobial drug usage and antimicrobial susceptibility of gram-positive mastitis pathogens. J Dairy Sci 90, 262-273, 2007.
23) Constable PD, Morin DE. Treatment of clinical mastitis. Using antimicrobial susceptibility profiles for treatment decisions. Vet Clin North Am Food Anim Pract 19(1), 139-155, 2003.
24) Seegers H, Fourichon C, Beaudeau F. Production effects related to mastitis and mastitis economics in dairy cattle herds. Vet Res 34, 475-491, 2003. 25) Shpigel NY, Winkler M, Ziv G, Saran A. Relationship between in vitro sensitivity of coliform pathogens in the udder and the outcome of treatment for clinical mastitis. Vet Rec 142, 135-137, 1998.
26) Taponen S, Jantunen A, Pyörälä E, Pyörälä S. Efficacy of targeted 5-day combined parenteral and intramammary treatment of clinical mastitis caused by penicillin-susceptible or penicillin-resistant staphylococcus aureus. Acta Vet Scand 44, 53-62, 2003.
27) Tikofsky LL, Barlow JW, Santisteban C, Schukken YH. A comparison of antimicrobial susceptibility patterns for staphylococcus aureus in organic and conventional dairy herds. Microb Drug Resist 9 Suppl 1, S39-45, 2003.